The binding of PD-1 ligand 1 (PD-L1) on neoplastic cells to PD-1 on T-lymphocytes produces inhibitory signals to T-cells, allowing the tumor cells to evade the host immune system [50,51,52,53,54,55]. Here, PDCD1 is linked to neoplasm.